Showing results (291-300 of 300) with videos related to
Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 300 results.
Nature Medicine|March 23, 2021
Post-acute COVID-19 syndromeAni Nalbandian, Kartik Sehgal, Aakriti Gupta, et al.NPJ Digital Medicine|April 14, 2021
Medical records-based chronic kidney disease phenotype for clinical care and "big data" observational and genetic studiesNing Shang, Atlas Khan, Fernanda Polubriaginof, et al.Kidney International Reports|September 22, 2025
Rationale and Design of the International Prospective Study of CKD of Uncertain Etiology in Agricultural CommunitiesJill F Lebov, Daniel R Brooks, Anna Aceituno, et al.JAMA Network Open|March 11, 2026
Precision Diagnosis in APOL1 Kidney Disease With the p.N264K M1 Protective VariantElena Martinelli, Juntao Ke, Atlas Khan, et al.The New England Journal of Medicine|May 16, 2019
Genomic Mismatch at LIMS1 Locus and Kidney Allograft RejectionNicholas J Steers, Yifu Li, Zahida Drace, et al.The Science of the Total Environment|May 23, 2025
Environmental exposure assessment in the international prospective study of Chronic Kidney Disease of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) research consortium: Design and protocol developmentMarvin González-Quiroz, Anna Aceituno, Shuchi Anand, et al.The New England Journal of Medicine|December 27, 2018
Diagnostic Utility of Exome Sequencing for Kidney DiseaseEmily E Groopman, Maddalena Marasa, Sophia Cameron-Christie, et al.Kidney International Reports|March 11, 2020
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and RationaleBarry I Freedman, Marva M Moxey-Mims, Amir A Alexander, et al.Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney diseaseYask Gupta, David J Friedman, Michelle McNulty, et al.Nature Communications|November 30, 2023
Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney diseaseYask Gupta, David J Friedman, Michelle T McNulty, et al.Pageof 30